GENEVA– A much larger tuberculosis drug-resistance problem exists than researchers previously thought. New global data on TB, published this month by the World Health Organization (WHO), highlight serious weaknesses in many national TB programs, increasing the potential for widespread TB drug resistance.
How did we reach this precarious state?
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.